46 results
8-K
EX-1.1
TRML
Tourmaline Bio Inc
26 Jan 24
Other Events
4:12pm
Assets Control of the U.S. Department of the Treasury (“OFAC”) or the U.S. Department of State, the United Nations Security Council, the European Union … subsidiaries have made all such filings and obtained all such approvals as may be required by the Food and Drug Administration of the U.S. Department
424B5
TRML
Tourmaline Bio Inc
26 Jan 24
Prospectus supplement for primary offering
4:08pm
institution and is subject to the diligence and reporting requirements in (1) above, it must enter into an agreement with the U.S. Department of the Treasury
424B5
TRML
Tourmaline Bio Inc
24 Jan 24
Prospectus supplement for primary offering
9:20pm
, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other things, that it undertake to identify accounts held
8-K
EX-99.1
tgqfgqzqd1u vb
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-10.1
kr61hx 3p6r
27 Oct 23
Departure of Directors or Certain Officers
5:17pm
8-K
EX-10.7
plx 2d01fjxmtz
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
EX-10.10
dwqfpd2jzes42erl8d
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
424B3
byk2 0p5pw
15 Sep 23
Prospectus supplement
6:31am
425
0gvlz8qzah3544
13 Sep 23
Business combination disclosure
9:14am
8-K
EX-99.1
86cw jv1b0wyg
13 Sep 23
Regulation FD Disclosure
9:13am
S-4/A
jhurdoeykd9vvq6ed88n
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
S-4
EX-10.6
rv8 sq4objno5jnb
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
6qvxwyt4omm5
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
425
4r5ektu
22 Jun 23
Business combination disclosure
9:12am